semaglutide pcos fertility CUAnschutz researchers have published a proof-of-concept study demonstrating that injectable may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS. “Women with PMOS Ozempic Babies”: Myth Busting PCOS

If you are a candidate for a structured medical weight loss program, starting now manages your current risks

BB: Shut up

Relaxation of lower esophageal sphincter: Some medications and GLP-1s can affect the lower esophageal sphincter, causing it to relax more than usual

Signs that you may be ready to increase your dose Your provider will typically consider a dose increase when: You have been on your current dose for at least 4 weeks with no significant side effects Nausea, vomiting, or stomach discomfort from the previous dose increase has resolved Your weight loss has plateaued at the current dose, and you have not yet reached your goal Your blood sugar levels (if you have diabetes) are not yet in your target range Signs you are not ready to increase Your provider will typically delay a dose increase if: You are still experiencing nausea, vomiting, diarrhea, or stomach pain from your current dose You have missed doses recently due to side effects You have experienced any serious adverse event at the current dose that has not fully resolved Do you need to reach 15 mg

at 2 mg/mL, 2.5 mL

Understand relevancy of impact How much of my customer base is or will be taking GLP-1s